Sarissa Capital Management LP 13F Portfolio
| Entity | Category | QoQ AUM Change | AUM (13F) | # of Holdings | Performance Rank | Equities Trend |
|---|---|---|---|---|---|---|
SC Sarissa Capital Management LP | Institutional Filer | ▼ 29.28% | $157.6M | 9 |
Current Portfolio Holdings
Showing all 9 reported positions by value
| # | Stock | Company Name | Sector | Shares Held | Market Value | % of Portfolio |
|---|---|---|---|---|---|---|
| 1 | INVA | Innoviva, Inc. | Healthcare | 2.1M | $49.7M | 31.50% |
| 2 | IRWD | Ironwood Pharmaceuticals, Inc. | Healthcare | 9.2M | $32.3M | 20.46% |
| 3 | AMRN | Amarin Corporation plc | Healthcare | 1.7M | $24.2M | 15.35% |
| 4 | NBIX | Neurocrine Biosciences, Inc. | Healthcare | 117K | $15.4M | 9.74% |
| 5 | CYTK | Cytokinetics, Incorporated | Healthcare | 229K | $15.1M | 9.56% |
| 6 | LNTH | Lantheus Holdings, Inc. | Healthcare | 167K | $12.7M | 8.03% |
| 7 | BHVN | Biohaven Ltd. | Healthcare | 563K | $4.8M | 3.02% |
| 8 | REGN | Regeneron Pharmaceuticals, Inc. | Healthcare | 4K | $3.2M | 2.05% |
| 9 | VOR | Vor Biopharma Inc. | Healthcare | 25K | $453K | 0.29% |
Showing 1 to 9 of 9 holdings